Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook

Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023

Published:2023-03-13 Issue:4 Volume:109 Page:658-659
ISSN:1743-9159
Container-title:International Journal of Surgery
language:en
Short-container-title:

Author:

Akash Shopnil¹,Khan Md. Shajib¹,Mukerjee Nobendu²³^ORCID,Bibi Shabana⁴⁵^ORCID

Affiliation:

1. Department of Pharmacy, Faculty of Allied Health Science, Daffodil International University, Daffodil Smart City, Ashulia, Savar, Dhaka, Bangladesh

2. Department of Microbiology, West Bengal State University, Kolkata, West Bengal, India

3. Department of Health Sciences, Novel Global Community Educational Foundation, Hebersham, New South Wales, Australia

4. Department of Biosciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan

5. Yunnan Herbal Laboratory, College of Ecology and Environmental Sciences, Yunnan University, Kunming, China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference3 articles.

1. SARS-CoV-2 Omicron variant: epidemiological features, biological characteristics, and clinical significance;Guo;Front Immunol,2022

2. Trends in disease severity and health care utilization during the early Omicron variant period compared with previous SARS-CoV-2 high transmission periods—United States, December 2020–January 2022;Iuliano;MMWR Morb Mortal Wkly Rep,2022

3. Covid-19: what do we know about XBB.1.5 and should we be worried?;Mahase;BMJ,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages;MedComm – Future Medicine;2024-06

2. CoVEx: SARS-CoV-2 Mutation Explorer for genomic surveillance;Infection, Genetics and Evolution;2023-12

3. Enumeration of olive derived lignan, pinoresinol for activity against recent Omicron variant spike protein for structure-based drug design, DFT, molecular dynamics simulations, and MMGBSA studies;Journal of Applied Genetics;2023-11-29

4. A Molecular Docking Study: Benzoxazolone Derivatives against SARS-CoV-2 Omicron Subvariant EG.5.1;CHEM METHODOL;2023

5. A commentary on ‘Re-emergence of SARS-CoV-2 Omicron subvariant XBB.1.5: present status, treatment, and future outlook – 2023’;International Journal of Surgery;2023-06-22